share_log

Winning Health Technology Group Co., Ltd.'s (SZSE:300253) 8.2% Loss Last Week Hit Both Individual Investors Who Own 60% as Well as Institutions

Winning Health Technology Group Co., Ltd.'s (SZSE:300253) 8.2% Loss Last Week Hit Both Individual Investors Who Own 60% as Well as Institutions

衛寧健康科技集團有限公司(深交所:300253)上週8.2%的虧損影響了擁有60%股份的個人投資者和機構。
Simply Wall St ·  2024/11/24 10:18

Key Insights

主要見解

  • The considerable ownership by retail investors in Winning Health Technology Group indicates that they collectively have a greater say in management and business strategy
  • The top 25 shareholders own 39% of the company
  • Insiders own 20% of Winning Health Technology Group
  • 衛寧健康科技集團中零售投資者所擁有的相當大比例股權表明,他們共同在管理和業務策略上擁有更大的發言權。
  • 前二十五大股東佔公司的39%。
  • 衛寧健康科技集團20%的股權歸內部人士所有。

To get a sense of who is truly in control of Winning Health Technology Group Co., Ltd. (SZSE:300253), it is important to understand the ownership structure of the business. We can see that retail investors own the lion's share in the company with 60% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

要了解誰真正控制着衛寧健康科技集團有限公司(SZSE:300253),重要的是要了解該企業的所有權結構。我們可以看到,零售投資者在該公司中擁有相當大比例的股權,佔比達60%。換句話說,該集團面臨着最大的上行潛力(或下行風險)。

Following a 8.2% decrease in the stock price last week, retail investors suffered the most losses, but institutions who own 21% stock also took a hit.

上週股價下跌了8.2%,零售投資者遭受了最大虧損,但佔有21%股份的機構投資者也受到了打擊。

Let's take a closer look to see what the different types of shareholders can tell us about Winning Health Technology Group.

讓我們仔細看看不同類型股東對衛寧健康科技集團能告訴我們什麼。

big
SZSE:300253 Ownership Breakdown November 24th 2024
SZSE:300253所有權拆解 2024年11月24日

What Does The Institutional Ownership Tell Us About Winning Health Technology Group?

機構持股告訴我們有關衛寧健康科技集團的什麼?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。

As you can see, institutional investors have a fair amount of stake in Winning Health Technology Group. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Winning Health Technology Group's historic earnings and revenue below, but keep in mind there's always more to the story.

正如您所見,機構投資者在衛寧健康科技集團中持有相當數量的股份。這意味着爲這些機構工作的分析師們已經研究了這支股票,並且他們看好。但和其他人一樣,他們也可能出錯。當多個機構擁有某隻股票時,總存在它們會進行『擁擠交易』的風險。當這樣的交易出錯時,多方可能會爭相快速賣出股票。這種風險在一個沒有增長曆史的公司中更高。您可以在下面看到衛寧健康科技集團的歷史收益和營業收入,但請記住故事並不止於此。

big
SZSE:300253 Earnings and Revenue Growth November 24th 2024
SZSE:300253於2024年11月24日的收益和營業收入增長

We note that hedge funds don't have a meaningful investment in Winning Health Technology Group. Looking at our data, we can see that the largest shareholder is Wei Zhou with 8.2% of shares outstanding. The second and third largest shareholders are Ying Wang and Shanghai Yunxin Venture Capital Co., Ltd., with an equal amount of shares to their name at 5.0%.

我們注意到對衛寧健康沒有大量投資的對沖基金。根據我們的數據,最大的股東是周偉擁有8.2%的股份。第二和第三大股東分別是王英和上海雲鑫創投有限公司,他們的股份比例相同,均爲5.0%。

Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

我們的研究表明,前25大股東共控制了公司股份的不到一半,這意味着公司的股份廣泛分散,沒有主導股東。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

我們的數據表明,私人公司持有公司的4.0%的股份。單單從這個事實上很難得出任何結論,因此它值得研究誰擁有這些私人公司。有時內部人或其他相關方通過單獨的私營公司持有上市公司的股份。

Insider Ownership Of Winning Health Technology Group

衛寧健康的內部持股情況

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間是不同的。我們的數據反映了個別內部人員,至少捕捉到了董事會成員。公司管理業務,但首席執行官即使是董事會成員也必須向董事會負責。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部人持股情況表明領導層思考和公司真正所有者一樣時,內部所有權是積極的。然而,高達內部人士所有權也可能爲公司內的小團體帶來巨大的權力。在某些情況下,這可能是負面的。

Our information suggests that insiders maintain a significant holding in Winning Health Technology Group Co., Ltd.. It has a market capitalization of just CN¥16b, and insiders have CN¥3.2b worth of shares in their own names. That's quite significant. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.

我們的信息顯示,內部人士在衛寧健康集團股份有限公司持有着相當大的股份。其市值僅爲人民幣160億,內部人士名下的股份價值爲32億人民幣。這相當可觀。大多數人會說,這表明在這樣規模的公司中,公司與股東有很好的一致性。您可以點擊這裏查看這些內部人士是否一直在買入或賣出。

General Public Ownership

一般大衆所有權

The general public, who are usually individual investors, hold a substantial 60% stake in Winning Health Technology Group, suggesting it is a fairly popular stock. This level of ownership gives investors from the wider public some power to sway key policy decisions such as board composition, executive compensation, and the dividend payout ratio.

一般大衆,通常是個人投資者,在衛寧健康集團持有相當可觀的60%股份,表明該股是一隻相當受歡迎的股票。這種所有權級別賦予更廣泛公衆的投資者一定程度的權力,可以影響董事會成員構成、高管薪酬以及股息支付比例等關鍵政策決策。

Next Steps:

下一步:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - Winning Health Technology Group has 1 warning sign we think you should be aware of.

我覺得查看公司的股東是非常有趣的。但爲了真正獲得深入的見解,我們也需要考慮其他信息。以風險爲例 - 衛寧健康有1個警告標誌,我們認爲你應該知道。

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果您像我一樣,可能希望考慮這家公司是否會增長或縮小。幸運的是,您可以查看此免費報告,顯示分析師對其未來的預測。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論